search
Back to results

New Score for Pseudo- Acanthosis Nigricans

Primary Purpose

Pseudo Acanthosis Nigricans

Status
Unknown status
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Glycolic acids peel 70%
Saline
Sponsored by
Kasr El Aini Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Pseudo Acanthosis Nigricans

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • mild to moderate severity
  • age > 18 years old

Exclusion Criteria:

  • Pregnant and lactating patients,
  • patients with systemic diseases as connective tissue disease, diabetes,
  • skin infection
  • use of immunosuppressive drugs
  • Susceptibility for post peel hazards as hyperpigmentation
  • scarring and keloidal tendency

Sites / Locations

  • Kasr El Ainy university hospital, Faulty of medicine,Cairo university

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

glycolic acid peel

Saline

Arm Description

Outcomes

Primary Outcome Measures

Percentage involvement
Degree of severity expressed as a percentage
Acanthosis Nigricans Area and Severity Index score
New Score calculating severity and area as a number minimum value is 0 and maximum value is 40 the higher the number of the score the worse the affection

Secondary Outcome Measures

Full Information

First Posted
April 21, 2020
Last Updated
April 22, 2020
Sponsor
Kasr El Aini Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04359485
Brief Title
New Score for Pseudo- Acanthosis Nigricans
Official Title
Use Of A Novel Quantitative Tool For Evaluation of Pseudo- Acanthosis Nigricans: Acanthosis Nigricans Area And Severity Index
Study Type
Interventional

2. Study Status

Record Verification Date
April 2020
Overall Recruitment Status
Unknown status
Study Start Date
August 1, 2019 (Actual)
Primary Completion Date
November 1, 2019 (Actual)
Study Completion Date
June 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Kasr El Aini Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Each side of the neck pseudo acanthosis nigricans was randomized in to either receiving glycolic acid peel or saline. Evaluation was done at baseline and after 3 sessions 2 weeks apart by percentage involvement and by ANASI score

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pseudo Acanthosis Nigricans

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Enrollment
20 (Actual)

8. Arms, Groups, and Interventions

Arm Title
glycolic acid peel
Arm Type
Experimental
Arm Title
Saline
Arm Type
Placebo Comparator
Intervention Type
Procedure
Intervention Name(s)
Glycolic acids peel 70%
Intervention Description
Glycolic acid peel 70% applied in 3 coats medium depth
Intervention Type
Other
Intervention Name(s)
Saline
Intervention Description
Sodium chloride
Primary Outcome Measure Information:
Title
Percentage involvement
Description
Degree of severity expressed as a percentage
Time Frame
6 months to 1 year
Title
Acanthosis Nigricans Area and Severity Index score
Description
New Score calculating severity and area as a number minimum value is 0 and maximum value is 40 the higher the number of the score the worse the affection
Time Frame
6 months to 1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: mild to moderate severity age > 18 years old Exclusion Criteria: Pregnant and lactating patients, patients with systemic diseases as connective tissue disease, diabetes, skin infection use of immunosuppressive drugs Susceptibility for post peel hazards as hyperpigmentation scarring and keloidal tendency
Facility Information:
Facility Name
Kasr El Ainy university hospital, Faulty of medicine,Cairo university
City
Cairo
Country
Egypt

12. IPD Sharing Statement

Learn more about this trial

New Score for Pseudo- Acanthosis Nigricans

We'll reach out to this number within 24 hrs